T. Rowe Price Investment Management, Inc. Bio N Tech Se Transaction History
T. Rowe Price Investment Management, Inc.
- $164 Billion
- Q3 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 4,833,642 shares of BNTX stock, worth $498 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
4,833,642
Previous 3,598,472
34.32%
Holding current value
$498 Million
Previous $383 Million
24.42%
% of portfolio
0.29%
Previous 0.24%
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
321Shares Held
43.6MCall Options Held
1.17MPut Options Held
1.38M-
Baillie Gifford & CO7.88MShares$812 Million0.61% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$436 Million1.69% of portfolio
-
Primecap Management CO Pasadena, CA3.87MShares$399 Million0.3% of portfolio
-
Dodge & Cox San Francisco, CA3.65MShares$376 Million0.21% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$195 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...